151 related articles for article (PubMed ID: 21871801)
1. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS
Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size.
Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T
Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346
[TBL] [Abstract][Full Text] [Related]
3. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
[TBL] [Abstract][Full Text] [Related]
4. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
[TBL] [Abstract][Full Text] [Related]
5. A preliminary report of breast cancer screening by positron emission mammography.
Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
[TBL] [Abstract][Full Text] [Related]
6. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
[TBL] [Abstract][Full Text] [Related]
7. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Positron Emission Mammography with
Yano F; Itoh M; Hirakawa H; Yamamoto S; Yoshikawa A; Hatazawa J
Asia Ocean J Nucl Med Biol; 2019; 7(1):13-21. PubMed ID: 30705907
[TBL] [Abstract][Full Text] [Related]
10. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
[TBL] [Abstract][Full Text] [Related]
11. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
13. Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.
Koolen BB; Vidal-Sicart S; Benlloch Baviera JM; Valdés Olmos RA
Nucl Med Commun; 2014 May; 35(5):446-52. PubMed ID: 24686195
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
Teixeira SC; Rebolleda JF; Koolen BB; Wesseling J; Jurado RS; Stokkel MP; Del Puig Cózar Santiago M; van der Noort V; Rutgers EJ; Valdés Olmos RA
AJR Am J Roentgenol; 2016 Jun; 206(6):1307-14. PubMed ID: 27058014
[TBL] [Abstract][Full Text] [Related]
16. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer.
Tafra L; Cheng Z; Uddo J; Lobrano MB; Stein W; Berg WA; Levine E; Weinberg IN; Narayanan D; Ross E; Beylin D; Yarnall S; Keen R; Sawyer K; Van Geffen J; Freimanis RL; Staab E; Adler LP; Lovelace J; Shen P; Stewart J; Dolinsky S
Am J Surg; 2005 Oct; 190(4):628-32. PubMed ID: 16164937
[TBL] [Abstract][Full Text] [Related]
17. Positron Emission Mammography Image Interpretation for Reduced Image Count Levels.
MacDonald LR; Hippe DS; Bender LC; Cotter EW; Voria PR; Hallam PS; Wang CL; Haseley DR; Kelly MM; Parikh JR; Beatty JD; Rogers JV
J Nucl Med; 2016 Mar; 57(3):348-54. PubMed ID: 26635337
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Diagnostic Performance of Three-Dimensional Positron Emission Mammography versus Whole Body Positron Emission Tomography in Breast Cancer.
Dai D; Song X; Wang M; Li L; Ma W; Xu W; Ma Y; Liu J; Zhang J; Liu P; Gu X; Su Y
Contrast Media Mol Imaging; 2017; 2017():5438395. PubMed ID: 29097927
[TBL] [Abstract][Full Text] [Related]
19. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
20. Positron emission mammography in the diagnosis of breast cancer. Is maximum PEM uptake value a valuable threshold for malignant breast cancer detection?
Müller FH; Farahati J; Müller AG; Gillman E; Hentschel M
Nuklearmedizin; 2016; 55(1):15-20. PubMed ID: 26627876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
